Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.

Kern S, Syrjanen JA, Blennow K, Zetterberg H, Skoog I, Waern M, Hagen CE, van Harten AC, Knopman DS, Jack CR Jr, Petersen RC, Mielke MM.

JAMA Neurol. 2018 Nov 12. doi: 10.1001/jamaneurol.2018.3459. [Epub ahead of print]

PMID:
30419087
2.

Comparison of PC and iPad administrations of the Cogstate Brief Battery in the Mayo Clinic Study of Aging: assessing cross-modality equivalence of computerized neuropsychological tests.

Stricker NH, Lundt ES, Edwards KK, Machulda MM, Kremers WK, Roberts RO, Knopman DS, Petersen RC, Mielke MM.

Clin Neuropsychol. 2018 Nov 10:1-25. doi: 10.1080/13854046.2018.1519085. [Epub ahead of print]

PMID:
30417735
3.

Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study.

Turcano P, Mielke MM, Bower JH, Parisi JE, Cutsforth-Gregory JK, Ahlskog JE, Savica R.

Neurology. 2018 Nov 7. pii: 10.1212/WNL.0000000000006643. doi: 10.1212/WNL.0000000000006643. [Epub ahead of print]

PMID:
30404780
4.

Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration.

Zeydan B, Tosakulwong N, Schwarz CG, Senjem ML, Gunter JL, Reid RI, Gazzuola Rocca L, Lesnick TG, Smith CY, Bailey KR, Lowe VJ, Roberts RO, Jack CR Jr, Petersen RC, Miller VM, Mielke MM, Rocca WA, Kantarci K.

JAMA Neurol. 2018 Oct 15. doi: 10.1001/jamaneurol.2018.3057. [Epub ahead of print]

PMID:
30326011
5.

Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: A population-based case-control study.

Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Stewart EA, Mielke MM, Kantarci K, Miller VM.

Maturitas. 2018 Nov;117:64-77. doi: 10.1016/j.maturitas.2018.09.002. Epub 2018 Sep 14.

PMID:
30314564
6.

Loss of Ovarian Hormones and Accelerated Somatic and Mental Aging.

Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Kirkland JL, LeBrasseur NK, Schafer MJ, Mielke MM, Kantarci K, Stewart EA, Miller VM.

Physiology (Bethesda). 2018 Nov 1;33(6):374-383. doi: 10.1152/physiol.00024.2018.

PMID:
30303778
7.

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging.

Vemuri P, Lesnick TG, Przybelski SA, Graff-Radford J, Reid RI, Lowe VJ, Zuk SM, Senjem ML, Schwarz CG, Gunter JL, Kantarci K, Machulda MM, Mielke MM, Petersen RC, Knopman DS, Jack CR Jr.

Ann Neurol. 2018 Sep 28. doi: 10.1002/ana.25346. [Epub ahead of print]

PMID:
30264411
8.

The Cross-Sectional and Longitudinal Associations Between IL-6, IL-10, and TNFα and Cognitive Outcomes in the Mayo Clinic Study of Aging.

Wennberg AMV, Hagen CE, Machulda MM, Knopman DS, Petersen RC, Mielke MM.

J Gerontol A Biol Sci Med Sci. 2018 Sep 25. doi: 10.1093/gerona/gly217. [Epub ahead of print]

PMID:
30256904
9.

Sex-related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes.

Espeland MA, Carmichael O, Yasar S, Hugenschmidt C, Hazzard W, Hayden KM, Rapp SR, Neiberg R, Johnson KC, Hoscheidt S, Mielke MM; Action for Health in Diabetes (Look AHEAD) Research Group.

Alzheimers Dement. 2018 Sep;14(9):1184-1192. doi: 10.1016/j.jalz.2018.05.015. Epub 2018 Jul 5.

PMID:
30201101
10.

Sex and gender in Alzheimer's disease - Does it matter?

Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS.

Alzheimers Dement. 2018 Sep;14(9):1101-1103. doi: 10.1016/j.jalz.2018.08.003. No abstract available.

PMID:
30196887
11.

Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.

Ramanan VK, Przybelski SA, Graff-Radford J, Castillo AM, Lowe VJ, Mielke MM, Roberts RO, Reid RI, Knopman DS, Jack CR, Petersen RC, Vemuri P.

J Alzheimers Dis. 2018;65(4):1345-1352. doi: 10.3233/JAD-180446.

PMID:
30149450
12.

The Association of Multimorbidity With Preclinical AD Stages and SNAP in Cognitively Unimpaired Persons.

Vassilaki M, Aakre JA, Kremers WK, Mielke MM, Geda YE, Alhurani RE, Dutt T, Machulda MM, Knopman DS, Vemuri P, Coloma PM, Schauble B, Lowe VJ, Jack CR Jr, Petersen RC, Roberts RO.

J Gerontol A Biol Sci Med Sci. 2018 Aug 13. doi: 10.1093/gerona/gly149. [Epub ahead of print]

PMID:
30124772
13.

Functional Activity and Neuropsychiatric Symptoms in Normal Aging and Mild Cognitive Impairment: The Mayo Clinic Study of Aging.

Krell-Roesch J, Cerhan LP, Machulda MM, Roberts RO, Mielke MM, Knopman DS, Syrjanen JA, Christianson TJ, Petersen RC, Geda YE.

Alzheimer Dis Assoc Disord. 2018 Aug 13. doi: 10.1097/WAD.0000000000000266. [Epub ahead of print] No abstract available.

PMID:
30106755
14.

Orthostatic Hypotension as a Prodromal Marker of α-Synucleinopathies-Reply.

Savica R, Boeve BF, Mielke MM.

JAMA Neurol. 2018 Sep 1;75(9):1155. doi: 10.1001/jamaneurol.2018.2251. No abstract available.

PMID:
30105350
15.

Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study.

Chan P, Saleem M, Herrmann N, Mielke MM, Haughey NJ, Oh PI, Kiss A, Lanctôt KL.

J Alzheimers Dis. 2018;64(4):1235-1246. doi: 10.3233/JAD-180030.

16.

Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of Aging.

van Harten AC, Mielke MM, Swenson-Dravis DM, Hagen CE, Edwards KK, Roberts RO, Geda YE, Knopman DS, Petersen RC.

Neurology. 2018 Jul 24;91(4):e300-e312. doi: 10.1212/WNL.0000000000005863. Epub 2018 Jun 29.

PMID:
29959257
17.

Understanding the impact of sex and gender in Alzheimer's disease: A call to action.

Nebel RA, Aggarwal NT, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, Mallampalli MP, Mormino EC, Scott L, Yu WH, Maki PM, Mielke MM.

Alzheimers Dement. 2018 Sep;14(9):1171-1183. doi: 10.1016/j.jalz.2018.04.008. Epub 2018 Jun 12.

PMID:
29907423
18.

Mediterranean Diet, Its Components, and Amyloid Imaging Biomarkers.

Vassilaki M, Aakre JA, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, Machulda MM, Alhurani RE, Staubo SC, Knopman DS, Petersen RC, Lowe VJ, Jack CR, Roberts RO.

J Alzheimers Dis. 2018;64(1):281-290. doi: 10.3233/JAD-171121.

PMID:
29889074
19.

Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging.

Wennberg AMV, Hagen CE, Edwards K, Roberts RO, Machulda MM, Knopman DS, Petersen RC, Mielke MM.

Int J Geriatr Psychiatry. 2018 Aug;33(8):1114-1120. doi: 10.1002/gps.4900. Epub 2018 Jun 5.

PMID:
29873112
20.

New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.

Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gold M, Kukull WA, Mohs R, Gauthier S, Molinuevo JL, Zetterberg H, Khachaturian ZS.

Alzheimers Dement. 2018 Jun;14(6):703-706. doi: 10.1016/j.jalz.2018.05.002. Epub 2018 May 26. No abstract available.

PMID:
29842864
21.

Impact of a History of Hypertension in Pregnancy on Later Diagnosis of Atrial Fibrillation.

Scantlebury DC, Kattah AG, Weissgerber TL, Agarwal S, Mielke MM, Weaver AL, Vaughan LE, Henkin S, Zimmerman K, Miller VM, White WM, Hayes SN, Garovic VD.

J Am Heart Assoc. 2018 May 13;7(10). pii: e007584. doi: 10.1161/JAHA.117.007584.

22.

Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.

Roberts RO, Aakre JA, Kremers WK, Vassilaki M, Knopman DS, Mielke MM, Alhurani R, Geda YE, Machulda MM, Coloma P, Schauble B, Lowe VJ, Jack CR Jr, Petersen RC.

JAMA Neurol. 2018 Aug 1;75(8):970-979. doi: 10.1001/jamaneurol.2018.0629.

PMID:
29710225
23.

Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.

Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gustafson DR, Kukull WA, Mohs R, Khachaturian ZS.

Alzheimers Dement. 2018 Apr;14(4):532-534. doi: 10.1016/j.jalz.2018.03.003. No abstract available.

PMID:
29653605
24.

Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.

Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, Airey DC, Knopman DS, Roberts RO, Machulda MM, Jack CR Jr, Petersen RC, Dage JL.

Alzheimers Dement. 2018 Aug;14(8):989-997. doi: 10.1016/j.jalz.2018.02.013. Epub 2018 Apr 5.

PMID:
29626426
25.

Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging.

Krell-Roesch J, Feder NT, Roberts RO, Mielke MM, Christianson TJ, Knopman DS, Petersen RC, Geda YE.

J Alzheimers Dis. 2018;63(1):149-155. doi: 10.3233/JAD-171141.

26.

The association between peripheral total IGF-1, IGFBP-3, and IGF-1/IGFBP-3 and functional and cognitive outcomes in the Mayo Clinic Study of Aging.

Wennberg AMV, Hagen CE, Machulda MM, Hollman JH, Roberts RO, Knopman DS, Petersen RC, Mielke MM.

Neurobiol Aging. 2018 Jun;66:68-74. doi: 10.1016/j.neurobiolaging.2017.11.017. Epub 2018 Feb 19.

PMID:
29547749
27.

Longitudinal tau PET in ageing and Alzheimer's disease.

Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, Weigand SD, Therneau TM, Knopman DS, Gunter JL, Jones DT, Graff-Radford J, Kantarci K, Roberts RO, Mielke MM, Machulda MM, Petersen RC.

Brain. 2018 May 1;141(5):1517-1528. doi: 10.1093/brain/awy059.

28.

Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia.

Carvalho DZ, St Louis EK, Knopman DS, Boeve BF, Lowe VJ, Roberts RO, Mielke MM, Przybelski SA, Machulda MM, Petersen RC, Jack CR Jr, Vemuri P.

JAMA Neurol. 2018 Jun 1;75(6):672-680. doi: 10.1001/jamaneurol.2018.0049.

PMID:
29532057
29.

Trajectories of plasma IGF-1, IGFBP-3, and their ratio in the Mayo Clinic Study of Aging.

Wennberg AMV, Hagen CE, Petersen RC, Mielke MM.

Exp Gerontol. 2018 Jun;106:67-73. doi: 10.1016/j.exger.2018.02.015. Epub 2018 Feb 21.

PMID:
29474865
30.

Joint associations of β-amyloidosis and cortical thickness with cognition.

Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC, Jack CR Jr.

Neurobiol Aging. 2018 May;65:121-131. doi: 10.1016/j.neurobiolaging.2018.01.017. Epub 2018 Feb 2.

PMID:
29471214
31.

When Do α-Synucleinopathies Start? An Epidemiological Timeline: A Review.

Savica R, Bradley BF, Mielke MM.

JAMA Neurol. 2018 Apr 1;75(4):503-509. doi: 10.1001/jamaneurol.2017.4243.

PMID:
29459985
32.

Frequency of Acute and Subacute Infarcts in a Population-Based Study.

Arnold Fiebelkorn C, Vemuri P, Rabinstein AA, Mielke MM, Przybelski SA, Kantarci K, Jones DT, Brown RD Jr, Knopman DS, Petersen RC, Jack CR Jr, Graff-Radford J.

Mayo Clin Proc. 2018 Mar;93(3):300-306. doi: 10.1016/j.mayocp.2017.11.021. Epub 2018 Feb 14.

PMID:
29426582
33.

Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly.

Fatemi F, Kantarci K, Graff-Radford J, Preboske GM, Weigand SD, Przybelski SA, Knopman DS, Machulda MM, Roberts RO, Mielke MM, Petersen RC, Jack CR Jr, Vemuri P.

Neurology. 2018 Feb 6;90(6):e466-e473. doi: 10.1212/WNL.0000000000004913. Epub 2018 Jan 17.

PMID:
29343465
34.

Longitudinal Association Between Brain Amyloid-Beta and Gait in the Mayo Clinic Study of Aging.

Wennberg AMV, Lesnick TG, Schwarz CG, Savica R, Hagen CE, Roberts RO, Knopman DS, Hollman JH, Vemuri P, Jack CR Jr, Petersen RC, Mielke MM.

J Gerontol A Biol Sci Med Sci. 2018 Aug 10;73(9):1244-1250. doi: 10.1093/gerona/glx240.

PMID:
29236984
35.

Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.

Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr.

Brain. 2018 Jan 1;141(1):271-287. doi: 10.1093/brain/awx320.

PMID:
29228201
36.

Plasma sphingolipids and depressive symptoms in coronary artery disease.

Dinoff A, Saleem M, Herrmann N, Mielke MM, Oh PI, Venkata SLV, Haughey NJ, Lanctôt KL.

Brain Behav. 2017 Sep 26;7(11):e00836. doi: 10.1002/brb3.836. eCollection 2017 Nov.

37.

Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging.

Krell-Roesch J, Lowe VJ, Neureiter J, Pink A, Roberts RO, Mielke MM, Vemuri P, Stokin GB, Christianson TJ, Jack CR, Knopman DS, Boeve BF, Kremers WK, Petersen RC, Geda YE.

Int Psychogeriatr. 2018 Feb;30(2):245-251. doi: 10.1017/S1041610217002368. Epub 2017 Dec 4.

38.

Cohort profile: the Mayo Clinic Cohort Study of Oophorectomy and Aging-2 (MOA-2) in Olmsted County, Minnesota (USA).

Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Stewart EA, Mielke MM, Kantarci K, Miller VM.

BMJ Open. 2017 Nov 20;7(11):e018861. doi: 10.1136/bmjopen-2017-018861.

39.

Prevalence and Natural History of Superficial Siderosis: A Population-Based Study.

Pichler M, Vemuri P, Rabinstein AA, Aakre J, Flemming KD, Brown RD Jr, Kumar N, Kantarci K, Kremers W, Mielke MM, Knopman DS, Jack CR Jr, Petersen RC, Lowe V, Graff-Radford J.

Stroke. 2017 Dec;48(12):3210-3214. doi: 10.1161/STROKEAHA.117.018974. Epub 2017 Oct 25.

PMID:
29070715
40.

Neurofilaments in blood: (Almost) facing clinical application.

Mielke MM, Otto M.

Neurology. 2017 Nov 21;89(21):2126-2127. doi: 10.1212/WNL.0000000000004675. Epub 2017 Oct 25. No abstract available.

PMID:
29070663
41.

Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial.

Sacktor N, Skolasky RL, Moxley R, Wang S, Mielke MM, Munro C, Steiner J, Nath A, Haughey N, McArthur J.

J Neurovirol. 2018 Feb;24(1):16-27. doi: 10.1007/s13365-017-0587-z. Epub 2017 Oct 23.

PMID:
29063516
42.

Overall Survival and Causes of Death in Neurodegeneration-An Overlooked and Underreported Theme-Reply.

Savica R, Mielke MM.

JAMA Neurol. 2017 Nov 1;74(11):1379-1380. doi: 10.1001/jamaneurol.2017.2877. No abstract available.

PMID:
29052692
43.

Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.

Roberts RO, Knopman DS, Syrjanen JA, Aakre JA, Vassilaki M, Kremers WK, Mielke MM, Machulda MM, Graff-Radford J, Geda YE, Vemuri P, Lowe V, Jack CR Jr, Petersen RC.

Neurology. 2017 Nov 14;89(20):2039-2048. doi: 10.1212/WNL.0000000000004652. Epub 2017 Oct 13.

PMID:
29030451
44.

Age, vascular health, and Alzheimer disease biomarkers in an elderly sample.

Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Lowe VJ, Graff-Radford J, Roberts RO, Mielke MM, Machulda MM, Petersen RC, Jack CR Jr.

Ann Neurol. 2017 Nov;82(5):706-718. doi: 10.1002/ana.25071. Epub 2017 Oct 26.

45.

Plasma Sphingolipids are Associated With Gait Parameters in the Mayo Clinic Study of Aging.

Wennberg AMV, Schafer MJ, LeBrasseur NK, Savica R, Bui HH, Hagen CE, Hollman JH, Petersen RC, Mielke MM.

J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):960-965. doi: 10.1093/gerona/glx139.

PMID:
28977376
46.

Sphingolipids in Alzheimer's Disease and Related Disorders.

Martinez Martinez P, Mielke MM.

J Alzheimers Dis. 2017;60(3):753-756. doi: 10.3233/JAD-170735. No abstract available.

PMID:
28922162
47.

Characterization of intravascular cellular activation in relationship to subclinical atherosclerosis in postmenopausal women.

Jayachandran M, Garovic VD, Mielke MM, Bailey KR, Lahr BD, Miller VM.

PLoS One. 2017 Sep 14;12(9):e0183159. doi: 10.1371/journal.pone.0183159. eCollection 2017.

48.

Carotid Artery Intima-Media Thickness and Subclinical Atherosclerosis in Women With Remote Histories of Preeclampsia: Results From a Rochester Epidemiology Project-Based Study and Meta-analysis.

Garovic VD, Milic NM, Weissgerber TL, Mielke MM, Bailey KR, Lahr B, Jayachandran M, White WM, Hodis HN, Miller VM.

Mayo Clin Proc. 2017 Sep;92(9):1328-1340. doi: 10.1016/j.mayocp.2017.05.030. Epub 2017 Aug 25.

49.

Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.

Turcano P, Mielke MM, Josephs KA, Bower JH, Parisi JE, Boeve BF, Savica R.

Mov Disord. 2017 Oct;32(10):1439-1446. doi: 10.1002/mds.27125. Epub 2017 Aug 26.

50.

1H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults.

Nedelska Z, Przybelski SA, Lesnick TG, Schwarz CG, Lowe VJ, Machulda MM, Kremers WK, Mielke MM, Roberts RO, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K.

Neurology. 2017 Sep 26;89(13):1391-1399. doi: 10.1212/WNL.0000000000004421. Epub 2017 Aug 25.

Supplemental Content

Loading ...
Support Center